Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk of Endometrial Cancer in Women Treated With Ovary‐stimulating Drugs for Subfertility." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435970/all/Risk_of_endometrial_cancer_in_women_treated_with_ovary‐stimulating_drugs_for_subfertility.
Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435970/all/Risk_of_endometrial_cancer_in_women_treated_with_ovary‐stimulating_drugs_for_subfertility. Accessed January 24, 2026.
Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435970/all/Risk_of_endometrial_cancer_in_women_treated_with_ovary‐stimulating_drugs_for_subfertility
Risk of Endometrial Cancer in Women Treated With Ovary‐stimulating Drugs for Subfertility [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435970/all/Risk_of_endometrial_cancer_in_women_treated_with_ovary‐stimulating_drugs_for_subfertility.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility
ID - 435970
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435970/all/Risk_of_endometrial_cancer_in_women_treated_with_ovary‐stimulating_drugs_for_subfertility
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

